Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Builders FirstSource heads into its October 29 earnings report with analyst sentiment turning more cautious and the stock down 14.5% over the past month to $56.22.
The sharpest move this week came from the Street. RBC Capital's Mike Dahl downgraded BLDR from Outperform to Sector Perform on October 7, cutting his price target to $62 from $88. That follows a pattern that has been building since the July earnings release, when a wave of firms maintained positive ratings but slashed targets by $20 to $35 each. UBS, Truist, Oppenheimer and Barclays all trimmed after the Q2 print. Then this week RBC went a step further and pulled the Outperform rating. The consensus now sits at Hold across 12 analysts, with two Outperforms and a mean target of $77.45, still a 38% premium to the current price. The gap between that target and where the stock is trading reflects a Street that has been perpetually optimistic about a housing recovery that keeps getting pushed out rather than analysts who have made a decisive bearish call.
The bull and bear cases are unusually well defined. Bulls point to BLDR's vertically integrated model, its $100 million cost programme and $50 to $70 million of FY26 productivity savings, and a business they believe is near a volume trough, with normalised EBITDA estimated at $2.25 billion against limited net debt. Bears flag that roughly 70% of revenues track single-family starts, that lagged starts point to year-on-year volume declines of around 4 to 5% in the current and next quarter, and that management's actual EBITDA has averaged around 20% below its own original guidance over the past two years. Net leverage ticked above 3x in Q1. The factor scores corroborate the bear case on near-term fundamentals: the EPS surprise rank sits at the 7th percentile and 90-day EPS momentum is in the bottom 6% of the universe, though 12-month forward EPS trajectory scores 77, suggesting consensus still prices in a multi-year recovery.
Short positioning has been building but remains far from extreme. Short interest reached 7.8% of free float, up roughly 8% over the past month, though it edged down 5% on October 6 alone to around 8.6 million shares. The borrow market is loose: availability is running at 1,650%, meaning there are well over 16 shares available to lend for every one already borrowed. Borrowing cost has risen sharply on a weekly basis, up 40%, but the absolute level of 0.44% remains trivial. The options market is actually leaning more bullish than usual. The put/call ratio is 0.56, sitting more than one standard deviation below its 20-day average of 0.61, a reading closer to the 52-week low of 0.41 than the 52-week high of 1.00. That divergence is worth noting: short interest has been creeping up over the month while options traders are not positioning for a sharp drop.
The institutional register adds one detail worth noting. BlackRock filed a 13G/A on October 5 showing its stake has grown to 12% of shares, up from 7.5% previously, an increase of more than 6.4 million shares to approximately 12.9 million held. That is a meaningful passive accumulation. Fidelity's FMR LLC, by contrast, cut from 10.3% to 3.3% as of its December 2025 filing. The insider table is less informative: all September trades were stock awards to directors, coded as grants rather than open-market purchases, and the 90-day net open-market figure is zero.
The previous Q2 earnings release on July 30 produced a one-day decline of 1.9% followed by a five-day gain of 7.0%, a pattern worth noting for context as the October 29 print approaches. The one-day dip and multi-day recovery reflects a market that tends to sell the headline and then reassess once the detail on margins and guidance is digested. Retail attention, as measured by Wikipedia page views, is running below BLDR's own 90-day average, with a z-score of negative 1.7, suggesting the stock has not attracted renewed broader interest despite the recent price weakness.
With 22 days to the next earnings release, what to watch is whether the RBC downgrade prompts further consensus erosion, and whether the volume and pricing data management provides in the October 29 update moves the gap between the $56 stock and the $77 mean target or closes it from the other direction.
See the live data behind this article on ORTEX.
Open BLDR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
